AbbVie, Inc. (ABBV)
288.24
-6.59
(-2.24%)
USD |
NYSE |
Nov 05, 16:00
286.17
-2.07
(-0.72%)
Pre-Market: 04:02
AbbVie Total Return Level : 499.52 for Nov. 5, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 05, 2026 | 499.52 |
| November 04, 2026 | 510.95 |
| November 03, 2026 | 495.64 |
| November 02, 2026 | 500.56 |
| October 30, 2026 | 511.05 |
| October 29, 2026 | 503.94 |
| October 28, 2026 | 495.63 |
| October 27, 2026 | 496.32 |
| October 26, 2026 | 496.93 |
| October 23, 2026 | 495.02 |
| October 22, 2026 | 494.24 |
| October 21, 2026 | 493.56 |
| October 20, 2026 | 500.98 |
| October 19, 2026 | 489.89 |
| October 16, 2026 | 494.64 |
| October 15, 2026 | 491.14 |
| October 14, 2026 | 488.29 |
| October 13, 2026 | 472.59 |
| October 12, 2026 | 484.23 |
| October 09, 2026 | 476.22 |
| October 08, 2026 | 469.24 |
| October 07, 2026 | 467.42 |
| October 06, 2026 | 459.37 |
| October 05, 2026 | 457.77 |
| October 02, 2026 | 452.71 |
| Date | Value |
|---|---|
| October 01, 2026 | 447.73 |
| September 30, 2026 | 450.59 |
| September 29, 2026 | 453.52 |
| September 28, 2026 | 458.67 |
| September 25, 2026 | 455.33 |
| September 24, 2026 | 456.67 |
| September 23, 2026 | 456.60 |
| September 22, 2026 | 456.82 |
| September 21, 2026 | 455.57 |
| September 18, 2026 | 454.67 |
| September 17, 2026 | 454.77 |
| September 16, 2026 | 452.17 |
| September 15, 2026 | 453.09 |
| September 14, 2026 | 450.90 |
| September 11, 2026 | 442.89 |
| September 10, 2026 | 439.24 |
| September 09, 2026 | 432.19 |
| September 08, 2026 | 428.52 |
| September 04, 2026 | 441.75 |
| September 03, 2026 | 448.21 |
| September 02, 2026 | 450.81 |
| September 01, 2026 | 447.83 |
| August 31, 2026 | 441.68 |
| August 28, 2026 | 440.06 |
| August 27, 2026 | 444.66 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 245.59 |
| Biogen, Inc. | 243.93 |
| Regeneron Pharmaceuticals, Inc. | 911.27 |
| Amgen, Inc. | 689.24 |
| REGENXBIO, Inc. | 7.38 |